SCHEMBL5469269

SCHEMBL5469269

O=C(O)N[C@H]1CC[C@H](NC(=O)Nc2ccccc2)CC1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 8/20 0.75
RAB9A P51151 6/20 0.75
EPHX2 P34913 5/20 0.75
SMN1; SMN2 Q16637 5/20 0.75
ALDH1A1 P00352 2/20 0.61
KMT2A Q03164 3/20 0.60
DRD2 P14416 1/20 0.60
DRD4 P21917 1/20 0.60
DRD3 P35462 1/20 0.60
FAAH O00519 1/20 0.59
NPC1 O15118 4/20 0.57
TP53 P04637 1/20 0.55
TSHR P16473 1/20 0.55
CDK9 P50750 1/20 0.55
CLK4 Q9HAZ1 1/20 0.55
CTSL P07711 1/20 0.55
CTSB P07858 1/20 0.55
CTSS P25774 1/20 0.55
CTSC P53634 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5469266 1.00 EPHX1 (0.75) EPHX1RAB9AEPHX2SMN1; SMN2ALDH1A1
SCHEMBL10825858 0.94 EPHX1 (0.83) EPHX1RAB9AEPHX2SMN1; SMN2ALDH1A1
SCHEMBL15263046 0.94 EPHX1 (0.83) EPHX1RAB9AEPHX2SMN1; SMN2ALDH1A1
SCHEMBL13949482 0.88 EPHX1 (0.73) EPHX1RAB9AEPHX2SMN1; SMN2ALDH1A1
SCHEMBL4266974 0.88 EPHX1 (0.73) EPHX1RAB9AEPHX2SMN1; SMN2ALDH1A1
SCHEMBL28218814 0.87 EPHX1 (0.90) EPHX1RAB9AEPHX2SMN1; SMN2ALDH1A1
SCHEMBL2752734 0.87 RAB9A (0.96) EPHX1RAB9AEPHX2SMN1; SMN2ALDH1A1
SCHEMBL23573481 0.86 EPHX1 (0.77) EPHX1RAB9AEPHX2SMN1; SMN2ALDH1A1
SCHEMBL584079 0.86 EPHX1 (0.71) EPHX1RAB9AEPHX2SMN1; SMN2ALDH1A1
SCHEMBL584080 0.86 EPHX1 (0.71) EPHX1RAB9AEPHX2SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135387-A1 Inhibitors of protein kinases ABBOTT LABORATORIES 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135387-A1 Inhibitors of protein kinases MAP3K20, PACSIN2, MAP4K2 EPHX1 3225/4885RAB9A 2192/4885EPHX2 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.